• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然产物作为肝脏保护剂——临床试验的全面综述

Natural Products as Hepatoprotective Agents-A Comprehensive Review of Clinical Trials.

作者信息

Służały Piotr, Paśko Paweł, Galanty Agnieszka

机构信息

Department of Pharmacognosy, Jagiellonian University Medical College, Medyczna 9, 30-688 Cracow, Poland.

Department of Food Chemistry and Nutrition, Jagiellonian University Medical College, Medyczna 9, 30-688 Cracow, Poland.

出版信息

Plants (Basel). 2024 Jul 20;13(14):1985. doi: 10.3390/plants13141985.

DOI:10.3390/plants13141985
PMID:39065511
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11280762/
Abstract

The hepatoprotective effects of natural products have been a significant focus in recent decades due to the growing demand for the help in the treatment of hepatic impairments. This review specifically delves into the findings of clinical trials involving 13 selected natural products, namely plants and their derived compounds (e.g., artichoke, berberine, and turmeric), algae (e.g., spirulina), probiotics, and other products like phospholipids and vitamin D. A literature search was performed in the Scopus database, PubMed, and Google Scholar, covering all articles found up to June 2024. Artichoke, berberine, chlorella, chicory, green tea, probiotics, phospholipids, schisandra, silymarin, spirulina, and vitamin D caused a decrease in liver enzymes, while for cinnamon and turmeric such an effect was either not observed or not convincing. The presented results indicate that some natural products might satisfactorily improve hepatic outcomes in NAFLD, NASH, and other liver disorders; however, further studies and metanalyses are needed to clearly demonstrate their effectiveness.

摘要

由于治疗肝脏损伤的需求不断增加,天然产物的肝脏保护作用在近几十年来一直是一个重要的研究重点。本综述特别深入探讨了涉及13种选定天然产物的临床试验结果,这些天然产物包括植物及其衍生化合物(如洋蓟、黄连素和姜黄)、藻类(如螺旋藻)、益生菌以及其他产品,如磷脂和维生素D。在Scopus数据库、PubMed和谷歌学术上进行了文献检索,涵盖了截至2024年6月找到的所有文章。洋蓟、黄连素、小球藻、菊苣、绿茶、益生菌、磷脂、五味子、水飞蓟素、螺旋藻和维生素D可使肝酶降低,而肉桂和姜黄则未观察到这种效果或效果不明显。所呈现的结果表明,一些天然产物可能会令人满意地改善非酒精性脂肪性肝病、非酒精性脂肪性肝炎和其他肝脏疾病的肝脏预后;然而,需要进一步的研究和荟萃分析来明确证明它们的有效性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe52/11280762/30ca22bd5f56/plants-13-01985-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe52/11280762/30ca22bd5f56/plants-13-01985-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe52/11280762/30ca22bd5f56/plants-13-01985-g001.jpg

相似文献

1
Natural Products as Hepatoprotective Agents-A Comprehensive Review of Clinical Trials.天然产物作为肝脏保护剂——临床试验的全面综述
Plants (Basel). 2024 Jul 20;13(14):1985. doi: 10.3390/plants13141985.
2
Medicinal plants used against hepatic disorders in Bangladesh: A comprehensive review.用于治疗孟加拉国肝脏疾病的药用植物:全面综述。
J Ethnopharmacol. 2022 Jan 10;282:114588. doi: 10.1016/j.jep.2021.114588. Epub 2021 Sep 1.
3
Chinese herbal medicines: The modulator of nonalcoholic fatty liver disease targeting oxidative stress.中草药:针对氧化应激的非酒精性脂肪肝疾病调节剂。
J Ethnopharmacol. 2024 Jan 10;318(Pt B):116927. doi: 10.1016/j.jep.2023.116927. Epub 2023 Jul 31.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
Hepatoprotective effects of natural drugs: Current trends, scope, relevance and future perspectives.天然药物的肝保护作用:当前趋势、范围、相关性和未来展望。
Phytomedicine. 2023 Dec;121:155100. doi: 10.1016/j.phymed.2023.155100. Epub 2023 Sep 18.
6
Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence.营养疗法治疗非酒精性脂肪性肝病(NAFLD):现有临床证据。
Nutrients. 2018 Aug 23;10(9):1153. doi: 10.3390/nu10091153.
7
Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD.草药和补充剂对非酒精性脂肪性肝病患者的潜在治疗益处。
Diseases. 2018 Sep 10;6(3):80. doi: 10.3390/diseases6030080.
8
Effects of different natural products in patients with non-alcoholic fatty liver disease-A network meta-analysis of randomized controlled trials.不同天然产物对非酒精性脂肪性肝病患者的影响:一项随机对照试验的网络荟萃分析。
Phytother Res. 2024 Jul;38(7):3801-3824. doi: 10.1002/ptr.8182. Epub 2024 Jun 17.
9
Drug-induced liver injury and anti-hepatotoxic effect of herbal compounds: a metabolic mechanism perspective.药物性肝损伤与草药化合物的抗肝毒性作用:代谢机制视角
Phytomedicine. 2024 Jan;122:155142. doi: 10.1016/j.phymed.2023.155142. Epub 2023 Oct 11.
10
Beneficial Effects of Plant-Derived Natural Products on Non-alcoholic Fatty Liver Disease.植物源天然产物对非酒精性脂肪性肝病的有益作用。
Adv Exp Med Biol. 2021;1308:257-272. doi: 10.1007/978-3-030-64872-5_18.

引用本文的文献

1
Dietary Strategies in the Prevention of MASLD: A Comprehensive Review of Dietary Patterns Against Fatty Liver.预防代谢相关脂肪性肝病的饮食策略:针对脂肪肝的饮食模式综合综述
Metabolites. 2025 Aug 4;15(8):528. doi: 10.3390/metabo15080528.
2
AMPK-Targeting Effects of (-)-Epicatechin Gallate from Linne Leaves on Dual Modulation of Hepatic Lipid Accumulation and Glycogen Synthesis in an In Vitro Oleic Acid Model.来自林奈叶的(-)-表儿茶素没食子酸酯对体外油酸模型中肝脂质积累和糖原合成双重调节的AMPK靶向作用
Int J Mol Sci. 2025 Aug 6;26(15):7612. doi: 10.3390/ijms26157612.
3
DIA-based quantitative proteomics explores the mechanism of amelioration of APAP-induced liver injury by anoectochilus roxburghii (Wall.) Lindl.

本文引用的文献

1
Probiotic supplementation for 24 weeks in patients with non-alcoholic steatohepatitis: the PROBILIVER randomized clinical trial.非酒精性脂肪性肝炎患者补充益生菌24周:PROBILIVER随机临床试验
Front Nutr. 2024 Mar 27;11:1362694. doi: 10.3389/fnut.2024.1362694. eCollection 2024.
2
The Beneficial Effects of Lactobacillus GG Therapy on Liver and Drinking Assessments in Patients with Moderate Alcohol-Associated Hepatitis.鼠李糖乳杆菌 GG 疗法对中重度酒精性肝炎患者肝脏和饮酒评估的有益影响。
Am J Gastroenterol. 2023 Aug 1;118(8):1457-1460. doi: 10.14309/ajg.0000000000002283. Epub 2023 Apr 11.
3
The effect of high oral loading dose of cholecalciferol in non-alcoholic fatty liver disease patients. A randomized placebo controlled trial.
基于数据非依赖采集的定量蛋白质组学探究金线莲改善对乙酰氨基酚诱导的肝损伤的机制。
Front Pharmacol. 2025 Mar 26;16:1508290. doi: 10.3389/fphar.2025.1508290. eCollection 2025.
4
A comprehensive review of Schisandrin B's preclinical antitumor activity and mechanistic insights from network pharmacology.五味子乙素临床前抗肿瘤活性及网络药理学机制洞察的综合综述
Front Pharmacol. 2025 Feb 10;16:1528533. doi: 10.3389/fphar.2025.1528533. eCollection 2025.
5
Metabolic-Associated Fatty Liver Disease: The Influence of Oxidative Stress, Inflammation, Mitochondrial Dysfunctions, and the Role of Polyphenols.代谢相关脂肪性肝病:氧化应激、炎症、线粒体功能障碍的影响及多酚的作用
Pharmaceuticals (Basel). 2024 Oct 10;17(10):1354. doi: 10.3390/ph17101354.
6
Spirulina/Arthrospira/Limnospira-Three Names of the Single Organism.螺旋藻/节旋藻/湖生螺旋藻——单一生物体的三个名称
Foods. 2024 Aug 30;13(17):2762. doi: 10.3390/foods13172762.
高口服负荷剂量胆钙化醇对非酒精性脂肪性肝病患者的影响。一项随机安慰剂对照试验。
Front Pharmacol. 2023 Mar 14;14:1149967. doi: 10.3389/fphar.2023.1149967. eCollection 2023.
4
Global burden of liver disease: 2023 update.全球肝病负担:2023 年更新。
J Hepatol. 2023 Aug;79(2):516-537. doi: 10.1016/j.jhep.2023.03.017. Epub 2023 Mar 27.
5
Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.膳食多酚补充剂治疗非酒精性脂肪性肝病的疗效和安全性:系统评价和荟萃分析。
Front Immunol. 2022 Sep 9;13:949746. doi: 10.3389/fimmu.2022.949746. eCollection 2022.
6
The Effect of Berberine on Lipid Profile, Liver Enzymes, and Fasting Blood Glucose in Patients with Non-alcoholic Fatty Liver Disease (NAFLD): A Randomized Controlled Trial.黄连素对非酒精性脂肪性肝病(NAFLD)患者血脂、肝酶及空腹血糖的影响:一项随机对照试验
Med J Islam Repub Iran. 2022 Apr 20;36:39. doi: 10.47176/mjiri.36.39. eCollection 2022.
7
Effect of Dietary Supplementation with Eufortyn Colesterolo Plus on Serum Lipids, Endothelial Reactivity, Indexes of Non-Alcoholic Fatty Liver Disease and Systemic Inflammation in Healthy Subjects with Polygenic Hypercholesterolemia: The ANEMONE Study.富含植物固醇的尤夫特宁降脂素对杂合子家族性高胆固醇血症人群血脂、血管内皮功能、非酒精性脂肪肝病及全身炎症指标的影响:ANEMONE 研究。
Nutrients. 2022 May 18;14(10):2099. doi: 10.3390/nu14102099.
8
The effect of sauce, as a functional food, on cardiometabolic risk factors, oxidative stress biomarkers, glycemic profile, and liver enzymes in nonalcoholic fatty liver disease patients: A randomized double-blinded clinical trial.酱汁作为一种功能性食品,对非酒精性脂肪性肝病患者的心脏代谢危险因素、氧化应激生物标志物、血糖谱和肝酶的影响:一项随机双盲临床试验。
Food Sci Nutr. 2021 Jun 11;10(2):317-328. doi: 10.1002/fsn3.2368. eCollection 2022 Feb.
9
The effect of turmeric on lipid profile, malondialdehyde, liver echogenicity and enzymes among patients with nonalcoholic fatty liver disease: a randomized double blind clinical trial.姜黄对非酒精性脂肪性肝病患者血脂、丙二醛、肝脏回声及酶的影响:一项随机双盲临床试验
Diabetol Metab Syndr. 2021 Oct 18;13(1):112. doi: 10.1186/s13098-021-00731-7.
10
A phase 2, proof of concept, randomised controlled trial of berberine ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetes.一项关于熊去氧胆酸黄连素治疗疑似非酒精性脂肪性肝炎合并 2 型糖尿病患者的 2 期概念验证随机对照试验。
Nat Commun. 2021 Sep 17;12(1):5503. doi: 10.1038/s41467-021-25701-5.